NCT03673787: A Trial of Ipatasertib in Combination With Atezolizumab
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 87 planned
- Started
- 13 Aug 2018
- Primary completion
- Mar 2026
- Arms
- Phase I, Phase II
- Results
- None posted
- 13 Aug 2018: Trial started
- 17 Sep 2018: Trial registered